Pursuant to Regulation 30 and 34 of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015. Please find attached the Annual Report for financial year ended 31st March ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
National Peroxide Ltd (formerly NPL Chemicals Limited), part of the Wadia Group and India's largest hydrogen peroxide maker (1,50,000 MTPA capacity), submitted its Annual Report for FY 2024-25 and the notice for its 5th AGM to BSE. The AGM is scheduled for September 4, 2025 at 3:30 PM via video conferencing. Financial performance was sharply weaker: total income fell to ₹29,136.11 lakhs from ₹33,814.95 lakhs, EBITDA dropped to ₹1,969.67 lakhs from ₹4,275.49 lakhs, and the company swung to a loss after tax of ₹(224.64) lakhs versus a profit of ₹1,679.03 lakhs last year. The Board did not declare any dividend for FY25, versus ₹12.50 per share paid for FY24. The company attributed the weakness to oversupply from new H2O2 plants, subdued demand, and price pressure. The AGM agenda includes re-appointment of Dr. Minnie Bodhanwala (retiring by rotation) and re-appointment of CEO Rajiv Arora for two years.
Weak FY25 results with revenue decline and a swing to loss, combined with a skipped dividend, are likely negative for shareholders. The oversupply-driven price pressure in hydrogen peroxide remains a near-term headwind, though the company highlights export expansion and value-added products as growth levers.